PROF Stock

Buy the stock on weakness. That’s the advice from Raymond James analyst Michael W. Freeman on ... Read More

Raymond James analyst Rahul Sarugaser has assigned a rare and bullish designation to Profound Medica... Read More

Following the company’s fourth quarter results, Leede Jones Gable analyst Doug Loe has maintai... Read More

  After a swoon in its share price that began several months ago, Raymond James analyst Rahul S... Read More

The stock has been white hot over the past eight months, but investors thinking there’s little lef... Read More